How many deaths from NCDs are there in the United States?

There were 32.2 million deaths from cancers, cardiovascular and chronic respiratory diseases, and diabetes and another 8.3 million from other NCDs.

How many countries are expected to achieve the SDG 3.4 by 2030?

Thirty five countries (19% of all countries) are expected to achieve Sustainable Development Goals (SDG) target 3.4 of one-third reduction, relative to their 2015 levels, in the probability of dying between 30 and 70 years of age from cancers, cardiovascular and chronic respiratory diseases, and diabetes by 2030 for women, and 30 (16%) are expected to do so for men, if they maintain or surpass their 2010-2016 rate of decline in mortality.

How many countries are progressing too slowly?

Another 86 countries (for women) and 97 (for men) are progressing too slowly, and need to implement policies that significantly increase the rates of decline, if they are to meet SDG target 3.4.NCD deaths beyond the age range and causes of death included in SDG target 3.4 cause a larger mortality burden in low- and middle-income countries than in high-income countries.

What is the purpose of the meeting?

The third UN High-Level Meeting on Non-Communicable Diseases (NCDs) in September 2018 will review national and global progress in prevention and control of NCDs and provides an opportunity to renew, reinforce and enhance commitments to reducing their burden.

How many deaths from NCDs are in the United Nations?

Of these, 1.7 million occurred before 30 years of age, 15.2 million between 30 and 70 years of age and 23.6 million in people aged 70 years and older.

What are the reasons for the higher mortality in low- and middle-income countries?

NCD causes and age groups other than those included in the SDG target 3.4 are responsible for a higher risk of death in low- and middle-income countries than in high-income countries.

How many countries are achieving the SDG 3.4?

Mortality from the four NCDs included in SDG target 3.4 has stagnated or increased since 2010 among women and men in 15 and 24 countries, respectively.

How many countries have seen a decrease in mortality from NCDs since 2010?

Mortality from the four NCDs included in SDG target 3.4 has stagnated or increased since 2010 among women and men in 15 (8%) and 24 (13%) countries, respectively.

What is the purpose of the NCD Countdown 2030?

NCD Countdown 2030 is an independent collaboration aiming to monitor and inform progress towards reducing the worldwide burden of NCDs.

Where did the highest risk of death from NCDs occur?

The highest risks of death from NCDs were experienced in low- and middle-income countries, especially in subSaharan Africa, and, for men, in central Asia and eastern Europe.

Where did the lowest levels of mortality in 2016 occur?

The lowest levels of NCD mortality in the world in 2016 were seen in high-income countries in the Asia-Pacific, western Europe and Australasia and in Canada.

(Open Access) NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4 (2018) | James E. Bennett

Most frequently asked questions

1. What contributions have the authors mentioned in the paper "Ncd countdown 2030: worldwide trends in non- communicable disease mortality and progress towards sustainable development goal target 3.4 author" ?

The first report from NCD Countdown 2030 evaluates the current worldwide status of mortality from non-communicable diseases and how likely it is, based on recent trends, to achieve significant reductions in mortality as agreed for SDG target 3.4 this paper.

2. What is the role of the UN in reducing NCD mortality?

Substantial reduction of NCD mortality requires policies that significantly reduce tobacco and alcohol use and blood pressure levels, and provide access to efficacious and high-quality preventive and curative care for NCDs in the context of UHC.

3. How many countries are expected to meet the SDG 3.4 target?

At current rates of decline in NCD mortality, SDG target 3.4 is expected to be met for women in 35 countries (19% of all countries) and men in 30 countries (16%).

4. What is the important factor in reducing NCD mortality?

For countries to substantially reduce NCD mortality requires policies that significantly reduce tobacco and alcohol use and blood pressure levels, and provide efficacious and high-quality preventive and curative care for NCDs, including timely diagnosis and treatment of hypertension, diabetes, and treatment-amenable cancers, and treatment pathways that improve the survival of those with acute and chronic NCDs.

NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4

Chat with Paper

AI Agents for this Paper

Most frequently asked questions

1. What contributions have the authors mentioned in the paper "Ncd countdown 2030: worldwide trends in non- communicable disease mortality and progress towards sustainable development goal target 3.4 author" ?

2. What is the role of the UN in reducing NCD mortality?

3. How many countries are expected to meet the SDG 3.4 target?

4. What is the important factor in reducing NCD mortality?

5. How many deaths from NCDs are there in the United States?

6. How many countries are expected to achieve the SDG 3.4 by 2030?

7. How many countries are progressing too slowly?

8. What is the purpose of the meeting?

9. How many deaths from NCDs are in the United Nations?

10. What are the reasons for the higher mortality in low- and middle-income countries?

11. How many countries are achieving the SDG 3.4?

12. How many countries have seen a decrease in mortality from NCDs since 2010?

13. What is the purpose of the NCD Countdown 2030?

14. Where did the highest risk of death from NCDs occur?

15. Where did the lowest levels of mortality in 2016 occur?

Citations

Healthcare utilisation, cancer screening and potential barriers to accessing cancer care in rural South West Nigeria: a cross-sectional study.

Socioeconomic inequalities in the risk factors of noncommunicable diseases (hypertension and diabetes) among Bangladeshi population: Evidence based on population level data analysis

Environmental impact on reproductive health and risk mitigating strategies.

Habilidades para la vida como elementos en la promoción y educación para la salud en los adolescentes y jóvenes

Factors Associated With County-Level Variation in Premature Mortality Due to Noncommunicable Chronic Disease in the United States, 1999-2017.

References

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

Health professionals for a new century: transforming education to strengthen health systems in an interdependent world

Maternal and child undernutrition: consequences for adult health and human capital.

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants

Health Professionals for a New Century: Transforming education to strengthen health systems in an interdependent world

Related Papers (5)

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016